BillionToOne
We push the boundaries of molecular diagnostics through quantitative technologies.
815 employees · est. 2016 · Menlo Park, United States
Surfix is the older company (2016 vs 2011); BillionToOne is the larger of the two.
Side-by-Side Comparison
| Metric | BillionToOne | Surfix |
|---|---|---|
| Founded | ||
| Founded | 2016 | 2011 older |
| Headquarters | ||
| Headquarters | Menlo Park, United States | Wageningen, The Netherlands |
| Employees | ||
| Employees | 815 larger | 38 |
| Industry | ||
| Industry | Biotechnology, Health Care | Biotechnology |
| Funding Stage | ||
| Funding Stage | IPO | Not tracked yet |
| Total Funding | ||
| Total Funding | $650.63M | Not tracked yet |
| Funding Rounds | ||
| Funding Rounds | 9 | Not tracked yet |
| Services | ||
| Services | Development and provision of advanced diagnostic tests, Quantification of disease-causing DNA fragments, Non-invasive prenatal and oncology testing solutions, Monitoring treatment response in cancer patients | Not tracked yet |
| Target Customers | ||
| Target Customers | Healthcare Providers, Pregnant Women, Oncologists, Medical Researchers | Not tracked yet |
| Taxonomy | ||
| Taxonomy | Molecular Diagnostics, Precision Diagnostics, DNA Quantification, Molecular Counting Technology, Disease Detection, Prenatal Testing, Single-gene Disorder Detection, Non-invasive Testing, Blood Test Innovation, Affordable Healthcare Solutions, Patent-pending Technology, Risk Reduction In Diagnostics, Biotechnology Innovation | Surfix Diagnostics, Diagnostics, Photonic Diagnostics Platform, Biosensor Technology, Cancer Detection, Early Detection, Liquid Biopsy, Microfluidics, Immunoassays, Molecular Diagnostics, Nanocoatings, Point-of-Care Testing, Biofunctionalization, Lab-on-a-Chip, Bioreceptor |
| Website | ||
| Website | billiontoone.com | surfixdx.com |
About BillionToOne
BillionToOne, founded in 2016, is a pioneering entity in the Biotechnology and Health Care industries, headquartered in the United States. The company is renowned for its commitment to enhancing the accuracy, efficiency, and accessibility of molecular diagnostics, encapsulated in their slogan: "We p...
About Surfix
Surfix Diagnostics, founded in 2011 and headquartered in The Netherlands, is a biotechnology startup with the goal of providing easy-to-use, reliable, and sensitive diagnostic tests for the early detection and monitoring of cancer. The company's photonic diagnostics platform integrates six cutting-e...
Be first to know when either one moves
Funding rounds, hiring surges, leadership changes and stack switches at BillionToOne and Surfix — tracked continuously, sent the day they land.
Funding, hiring, leadership and stack changes at BillionToOne and Surfix — by email.
Frequently Asked Questions
Compare BillionToOne with someone else
Start typing a company name or domain.